Carasent ASA Stock Nasdaq Stockholm
Stocks
CARAO
NO0010123060
Advanced Medical Equipment & Technology
OTC Markets Traded
| Market Cap | 1.66B 175M 151M 139M 130M 243M 16.58B 248M 1.64B 639M 8.13B 658M 644M 28.04B | P/E Ratio 2026 * |
55.1x | P/E Ratio 2027 * | 28.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.56B 165M 142M 131M 123M 229M 15.62B 233M 1.54B 602M 7.66B 620M 606M 26.42B | EV / Sales 2026 * |
3.92x | EV / Sales 2027 * | 3.13x |
| Free-Float |
66.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Carasent ASA
| 1 day | -3.90% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.90% | -54.08% | - | - | 169M | |
| +0.75% | -2.31% | -42.18% | -18.85% | 26.34B | |
| -0.27% | -0.92% | -39.33% | +148.16% | 12.18B | |
| -1.64% | -5.02% | -8.41% | +50.00% | 6B | |
| -2.35% | +12.65% | - | - | 2.83B | |
| -0.23% | -4.89% | +36.41% | -44.83% | 1.82B | |
| -1.55% | +4.62% | - | - | 1.74B | |
| +0.17% | +6.83% | -28.45% | - | 1.32B | |
| +0.28% | -3.00% | -33.08% | -59.36% | 813M | |
| +0.56% | -0.09% | -29.46% | +207.10% | 786M | |
| Average | -0.82% | +0.67% | -20.64% | +47.04% | 5.98B | |
| Weighted average by Cap. | -0.05% | -1.29% | -33.74% | +34.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 398M 42.08M 36.2M 33.29M 31.31M 58.42M 3.98B 59.47M 393M 153M 1.95B 158M 155M 6.73B | 476M 50.26M 43.25M 39.76M 37.4M 69.78M 4.76B 71.04M 469M 183M 2.33B 189M 185M 8.04B |
| Net income | 31.63M 3.34M 2.88M 2.64M 2.49M 4.64M 316M 4.72M 31.19M 12.18M 155M 12.54M 12.27M 535M | 60.18M 6.36M 5.47M 5.03M 4.73M 8.83M 602M 8.99M 59.34M 23.18M 295M 23.86M 23.36M 1.02B |
| Net Debt | -95.93M -10.14M -8.72M -8.02M -7.54M -14.07M -959M -14.33M -94.59M -36.95M -470M -38.04M -37.23M -1.62B | -171M -18.06M -15.54M -14.28M -13.44M -25.07M -1.71B -25.52M -168M -65.82M -838M -67.76M -66.32M -2.89B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
